Achilles Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	86.05	131.54	173.34	266.32	177.85	97.59
Short-Term Investments	-	-	-	-	-	0.27
Cash & Short-Term Investments	86.05	131.54	173.34	266.32	177.85	97.86
Cash Growth	-38.59%	-24.11%	-34.91%	49.74%	81.74%	816.02%
Other Receivables	21.79	10.35	16	11.17	7.34	4.49
Receivables	21.79	10.35	16	11.17	7.34	4.49
Prepaid Expenses	1.47	1.76	4.62	5.13	0.77	0.24
Other Current Assets	2.32	1.98	2.62	2.12	1.84	0.48
Total Current Assets	111.63	145.63	196.58	284.75	187.8	103.06
Property, Plant & Equipment	9.23	13.54	20.48	28.79	28.11	2.11
Long-Term Deferred Tax Assets	0.04	0.04	0.25	0.03	0	-
Other Long-Term Assets	1.78	2.24	3.05	3.54	3.01	0.03
Total Assets	122.68	161.46	220.36	317.11	218.92	105.21
Accounts Payable	4.25	5.63	5.19	3.72	6.31	0.9
Accrued Expenses	9.36	6.86	6.87	8.93	5.79	1.79
Current Portion of Leases	3.62	3.54	4.19	4.48	3.71	0.49
Current Income Taxes Payable	-	-	0.33	-	0.01	-
Other Current Liabilities	1.24	0.97	1.43	1.98	0.81	0.68
Total Current Liabilities	18.47	17	17.99	19.11	16.62	3.86
Long-Term Leases	-	1.08	4.39	7.78	12.27	-
Other Long-Term Liabilities	1.07	1.02	0.93	0.69	0.65	-
Total Liabilities	19.54	19.09	23.31	27.58	29.55	3.86
Common Stock	0.05	0.05	0.05	0.05	0.01	0.01
Additional Paid-In Capital	419.1	415.21	408.84	401.82	234.92	117.96
Retained Earnings	-308.2	-259.95	-190.29	-119.11	-58.01	-24.81
Comprehensive Income & Other	-7.81	-12.94	-21.57	6.76	12.32	8.11
Total Common Equity	103.14	142.37	197.04	289.53	189.24	101.27
Shareholders' Equity	103.14	142.37	197.04	289.53	189.37	101.35
Total Liabilities & Equity	122.68	161.46	220.36	317.11	218.92	105.21
Total Debt	3.62	4.62	8.58	12.26	15.98	0.49
Net Cash (Debt)	82.43	126.92	164.76	254.06	161.87	97.37
Net Cash Growth	-37.92%	-22.96%	-35.15%	56.96%	66.23%	811.47%
Net Cash Per Share	2.04	3.18	4.21	8.87	151.81	151.63
Filing Date Shares Outstanding	41.1	41.08	40.93	40.6	4.37	2.53
Total Common Shares Outstanding	41.1	41.08	40.93	40.6	4.39	2.53
Working Capital	93.16	128.64	178.59	265.64	171.17	99.2
Book Value Per Share	2.51	3.47	4.81	7.13	43.11	39.96
Tangible Book Value	103.14	142.37	197.04	289.53	189.24	101.27
Tangible Book Value Per Share	2.51	3.47	4.81	7.13	43.11	39.96
Machinery	12.98	12.64	11.32	9.82	6.52	1.72
Construction In Progress	-	-	-	5.35	1.28	0.29
Leasehold Improvements	10.09	9.45	8.93	7.02	6.96	0.15

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q